Corbus Pharmaceuticals Holdings, Inc.
CRBPNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $84.04M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.37$20.56
- Volume (live)
- -
- Avg. volume (3M)
- 1.26M
Corbus Pharmaceuticals Holdings (CRBP) Stock Price & Financial Analysis
Corbus Pharmaceuticals Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.22 - $4.72 |
|---|---|
| 52-Week High | $20.56 |
| 52-Week Low | $4.37 |
| Open | $4.35 |
| Volume (last close) | 1.07M |
| Average Volume (3M) | 1.26M |
| 50-Day MA | $8.53 |
|---|---|
| 200-Day MA | $8.85 |
| 1-Year Change | −77.59% |
| Market Cap | 84.04M |
|---|---|
| Shares Outstanding | 19.41M |
| Price to Book (P/B) | 0.82 |
| EV/EBITDA | -0.63 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Corbus Pharmaceuticals Holdings at a Glance
As of the Oct 16, 2026 close, Corbus Pharmaceuticals Holdings (CRBP) has a market capitalization of $84.04M.
As of its latest reported balance sheet, it holds $23.37M in cash and securities against $4.26M of debt, a net cash position of $19.11M.
Corbus Pharmaceuticals Holdings does not currently pay a dividend.
The share price is down 77.6% over the past year. At $4.52 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $4.37 to $20.56, below its 200-day moving average of $8.85.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $36.67, 711.3% above the Oct 16, 2026 close.
Frequently Asked Questions About Corbus Pharmaceuticals Holdings
What is the current stock price for CRBP?
As of the Oct 16, 2026 close, CRBP stock trades at $4.52. The 52-week range is $4.37–$20.56, with a day range of $4.22–$4.72.
What is the P/E ratio for CRBP?
The P/E ratio (Price-to-Earnings) for CRBP is shown in the Key Statistics section. This valuation metric helps compare Corbus Pharmaceuticals Holdings, Inc. to industry peers.
Does CRBP pay dividends?
Corbus Pharmaceuticals Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRBP?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for CRBP is Buy. The average 12-month price target is $36.67, a 711.3% upside from the Oct 16, 2026 close of $4.52.
What is the market cap of CRBP?
As of the Oct 16, 2026 close, Corbus Pharmaceuticals Holdings's market capitalization is $87.7M, classifying it as a micro-cap company. Corbus Pharmaceuticals Holdings operates in the Healthcare sector within the Biotechnology industry.